Detalhe da pesquisa
1.
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.
EMBO J
; 42(4): e110620, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36637036
2.
Vasohibin-1 Expression Can Predict Pathological Complete Remission of Advanced Bladder Cancer with Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 31(5): 2951-2958, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376711
3.
Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
World J Urol
; 42(1): 192, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530492
4.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517658
5.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538963
6.
Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.
Jpn J Clin Oncol
; 52(4): 388-396, 2022 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106598
7.
How long should urologists observe patients with prostate cancer after radical prostatectomy? Weibull analysis.
Int J Urol
; 29(4): 304-308, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981583
8.
Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma.
Int J Mol Sci
; 23(9)2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35563543
9.
The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
Cancer Sci
; 112(3): 1084-1094, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368857
10.
Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer.
Ann Surg Oncol
; 28(9): 5349-5359, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33666810
11.
Conditional Survival and Time of Biochemical Recurrence of Localized Prostate Cancer in Japanese Patients Undergoing Laparoscopic Radical Prostatectomies.
Ann Surg Oncol
; 28(2): 1247-1253, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651696
12.
Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching.
Ann Surg Oncol
; 28(1): 465-473, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32840743
13.
Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
Eur Radiol
; 31(2): 875-883, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829418
14.
Guideline adherence for radical cystectomy significantly affects survival outcomes in non-muscle-invasive bladder cancer patients.
Jpn J Clin Oncol
; 51(8): 1303-1312, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34009374
15.
Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.
Jpn J Clin Oncol
; 51(6): 984-991, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589927
16.
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer.
Jpn J Clin Oncol
; 51(2): 287-295, 2021 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32893303
17.
Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer.
Int J Clin Oncol
; 26(11): 2094-2103, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34357470
18.
Role of the MUC1-C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma.
Cancer Sci
; 111(10): 3639-3652, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32677159
19.
Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.
Int J Clin Oncol
; 25(6): 1163-1169, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125546
20.
Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer: Its definition and future therapeutic strategies.
Int J Urol
; 27(2): 108-116, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31793703